Equity Overview
Price & Market Data
Price: $12.28
Daily Change: -$0.26 / 2.12%
Range: $11.36 - $12.58
Market Cap: $79,560,144
Volume: 34,405
Performance Metrics
1 Week: 6.76%
1 Month: 59.01%
3 Months: 108.4%
6 Months: -48.60%
1 Year: -16.66%
YTD: -46.79%
Company Details
Employees: 14
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.